Domperidone Increases Harmful Cardiac Events in Parkinson's Disease: A Bayesian Re-Analysis of an Observational Study

Over the last two decades, Bayesian methods have gained popularity and their implementations have widened in statistical sciences and applied fields. From a healthcare perspective, regulatory agencies are now accepting Bayesian approaches for earlier phases of drug development [1,2] and comparative effectiveness research [3,4]. At the drug development level, Bayesian adaptive analytical approaches have been particularly attractive for achieving greater efficiency in reducing sample size, time and cost of trials [5].
Source: Journal of Clinical Epidemiology - Category: Epidemiology Authors: Source Type: research